Articles On Pancreatic Cancer
Pancreatic
cancer arises when
cells within the pancreas, a glandular organ behind the stomach, begin to multiply out of control and form a mass. These cancerous
cells have the power to invade other parts of the body. There are variety of sorts of carcinoma. The most common, pancreatic adenocarcinoma, accounts for about 90% of cases, and therefore the term "pancreatic cancer" is usually wont to refer only thereto type. These adenocarcinomas start within the part of the pancreas which makes digestive enzymes. Several other sorts of cancer, which collectively represent the bulk of the non-adenocarcinomas, also can arise from these cells. One to 2 percent of cases of
carcinoma are
neuroendocrine tumors, which arise from the hormone-producing
cells of the pancreas. These are generally less aggressive than pancreatic adenocarcinoma. Signs and symptoms of the most-common sort of
carcinoma may include yellow skin, abdominal or back pain, unexplained weight loss, light-colored stools, dark urine, and loss of appetite. There are usually no symptoms within the disease's early stages, and symptoms that are specific enough to suggest
carcinoma typically don't develop until the disease has reached an advanced stage. By the time of diagnosis,
carcinoma has often spread to other parts of the body.
High Impact List of Articles
-
Rationale for the use of multiple blockers of the renin-angiotensin-aldosterone system in specific patient populations
Fadi G Hage, Sulaf J Mansur and Suzanne Oparil
Review Article: Clinical Practice
-
Rationale for the use of multiple blockers of the renin-angiotensin-aldosterone system in specific patient populations
Fadi G Hage, Sulaf J Mansur and Suzanne Oparil
Review Article: Clinical Practice
-
Use of lubiprostone in constipating disorders and its potential for opioid-induced bowel dysfunction
Egilius LH Spierings
Drug Evaluation: Clinical Practice
-
Use of lubiprostone in constipating disorders and its potential for opioid-induced bowel dysfunction
Egilius LH Spierings
Drug Evaluation: Clinical Practice
-
Rosiglitazone evaluated for cardiovascular outcomes - an interim analysis
Gul Bahtiyar, Girardin Jean-Louis, Fiby Nessim and Samy I McFarlane
Research Highlights: Clinical Practice
-
Rosiglitazone evaluated for cardiovascular outcomes - an interim analysis
Gul Bahtiyar, Girardin Jean-Louis, Fiby Nessim and Samy I McFarlane
Research Highlights: Clinical Practice
-
Treatment of atrophic vaginitis
Camil Castelo-Branco and Fabiola Rostro
Review Article: Clinical Practice
-
Treatment of atrophic vaginitis
Camil Castelo-Branco and Fabiola Rostro
Review Article: Clinical Practice
-
Appendices: Volume 1 Issue 1
Appendices: Clinical Practice
-
Appendices: Volume 1 Issue 1
Appendices: Clinical Practice
-
Phase II study of salvage therapy with high-dose tamoxifen and oral etoposide for recurrent malignant glioma
Susan M Chang, Kathleen R Lamborn, Mary Malec, Jane Rabbitt, Margaretta Page and Michael D Prados
Research Article: Clinical Practice
-
Phase II study of salvage therapy with high-dose tamoxifen and oral etoposide for recurrent malignant glioma
Susan M Chang, Kathleen R Lamborn, Mary Malec, Jane Rabbitt, Margaretta Page and Michael D Prados
Research Article: Clinical Practice
Relevant Topics in Clinical